Cargando…
Psoriasis and Metabolic Syndrome – scientific evidence and therapeutic implications
Psoriasis is a chronic inflammatory disease, predominantly affecting the skin, being included in the group of Immune Mediated Inflammatory Diseases. Growing evidence from the last 10 years suggests that several systemic conditions like metabolic syndrome, cardiovascular disease, diabetes, psychologi...
Autores principales: | Voiculescu, VM, Lupu, M, Papagheorghe, L, Giurcaneanu, C, Micu, E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Carol Davila University Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4316120/ https://www.ncbi.nlm.nih.gov/pubmed/25713604 |
Ejemplares similares
-
Gene polymorphisms of TNF-238G/A, TNF-308G/A, IL10-1082G/A, TNFAIP3, and MC4R and comorbidity occurrence in a Romanian population with psoriasis
por: Voiculescu, Vlad Mihai, et al.
Publicado: (2018) -
Cutaneous adverse reactions specific to epidermal growth
factor receptor inhibitors
por: Lupu, I, et al.
Publicado: (2015) -
Psoriasis and metabolic syndrome: implications for the management and treatment of psoriasis
por: Wu, J.J., et al.
Publicado: (2022) -
Proteomic Approaches to Biomarker Discovery in Cutaneous T-Cell Lymphoma
por: Ion, Alexandra, et al.
Publicado: (2016) -
Psoriasis and Metabolic Syndrome: Comorbidities and Environmental and Therapeutic Implications
por: Peralta, Cesar, et al.
Publicado: (2019)